Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?

被引：0
|
作者：
Backes, F. [1 ]
Richardson, D. [2 ]
McCann, G. [1 ]
Salani, R. [1 ]
Eisenhauer, E. [1 ]
Fowler, J. [1 ]
Copeland, L. [1 ]
Cohn, D. [1 ]
O'Malley, D. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Univ Texas SW, Dallas, TX USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
225
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] Bevacizumab improves progression-free survival in ovarian cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 371 - 371
  • [32] Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
    Richardson, Debra L.
    Backes, Floor J.
    Seamon, Leigh G.
    Zanagnolo, Vanna
    O'Malley, David M.
    Cohn, David E.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (03) : 461 - 466
  • [33] Continued Exploration of Bevacizumab in Breast Cancer
    Mehta, Rita S.
    Su, Min-Ying
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 655 - 656
  • [34] Bevacizumab: hope after progression
    Mina Razzak
    Nature Reviews Clinical Oncology, 2013, 10 (1) : 2 - 2
  • [35] Bevacizumab in the treatment of ovarian cancer
    Han, Ernest S.
    Monk, Bradley J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1339 - 1345
  • [36] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    D A Reardon
    J E Herndon
    K B Peters
    A Desjardins
    A Coan
    E Lou
    A L Sumrall
    S Turner
    E S Lipp
    S Sathornsumetee
    J N Rich
    J H Sampson
    A H Friedman
    S T Boulton
    D D Bigner
    H S Friedman
    J J Vredenburgh
    British Journal of Cancer, 2012, 107 : 1481 - 1487
  • [37] ROLE OF BEVACIZUMAB IN OVARIAN CANCER
    Gonzalez Martin, Antonio
    IUBMB LIFE, 2009, 61 (03) : 291 - 291
  • [38] Bevacizumab in the Treatment of Ovarian Cancer
    Florian Heitz
    Philipp Harter
    Jana Barinoff
    Bianca Beutel
    Paevi Kannisto
    Jacek P. Grabowski
    Julia Heitz
    Christian Kurzeder
    Andreas du Bois
    Advances in Therapy, 2012, 29 : 723 - 735
  • [39] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    Reardon, D. A.
    Herndon, J. E., II
    Peters, K. B.
    Desjardins, A.
    Coan, A.
    Lou, E.
    Sumrall, A. L.
    Turner, S.
    Lipp, E. S.
    Sathornsumetee, S.
    Rich, J. N.
    Sampson, J. H.
    Friedman, A. H.
    Boulton, S. T.
    Bigner, D. D.
    Friedman, H. S.
    Vredenburgh, J. J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1481 - 1487
  • [40] Bevacizumab in the treatment of ovarian cancer
    Eskander, Ramez N.
    Randall, Leslie M.
    BIOLOGICS-TARGETS & THERAPY, 2011, 5 : 1 - 5
12345